glp-1 aurora Supplement for Weight Management & Cravings GLP-1 Drug Pipeline 2026 |

& Sanders, E

Animal studies have explored intranasal peptide delivery for CNS targets, but no published data confirms this pathway works for BPC-157 specifically at therapeutic concentrations

If the proposed mechanism (gradual synaptic plasticity effects) is right, daily dosing might be needed for sustained effect

When postprandial glucose and/or fasting blood glucose are sufficiently high, the polyol pathway (and OxS) will be activated in cells relying on GLUT1, e.g., endothelial cells [109,110]

Many PASC patients (89%) report CV symptoms including chest pain (53%), palpitations (68%), and new onset of postural orthostatic tachycardia syndrome (POTS, 31%) 193